Full Length Research Paper
References
|
Douglas SJ, Illum L, Davis SS (1984). Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors. J. Colloid Interface Sci. 101(1):149-58. crossref |
||||
|
Douglas SJ, Illum L, Davis SS (1986). Poly (butyl-2-cyanoacrylate) nanoparticles with differing surface charges. J. Control Release 15-23. crossref |
||||
|
Fontana G, Pitarresi G, Tomarchio V, Carlisi B, San Biagio PL (1998). Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles. Biomaterials 19(11-12):1009-17. crossref |
||||
|
Franciolli M, Bille J, Glauser MP, Moreillon P (1991). Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 163(3):514-23. crossref |
||||
|
Garay-Jimenez JC, Gergeres D, Young A, Lim DV, Turos E (2009). Physical properties and biological activity of poly(butyl acrylate-styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants. Nanomedicine 5(4):443-51. crossref |
||||
|
Hartman B, Tomasz A (1981). Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 19(5):726-35. crossref |
||||
|
Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C (2002). Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials 23(15):3193-201. crossref |
||||
|
Leeb M (2004) Antibiotics: a shot in the arm, Nature 431:892 -893. crossref |
||||
|
Litzinger DC, Buiting AM, van Rooijen N, Huang L (1994). Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1190(1):99-107. crossref |
||||
|
Liu PF, Lo CW, Chen CH, Hsieh MF, Huang CM (2009). Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus Infections. Curr. Drug Metab. 10(8):875-84. crossref |
||||
|
McCarron PA, Woolfson AD, Keating SM (1999).　Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles. Int J Pharm 193(1):37-47. crossref |
||||
|
Norrby SR, Nord CE, Finch R (2005). Lack of development of new antimicrobial drugs: a potential serious threat to public health, Lancet Infect. Dis. 5:115-119. crossref |
||||
|
Piddock LJ, Traynor EA, Griggs DJ (1992). Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 11(4): 364-71 crossref |
||||
|
Snyder DS, McIntosh TJ (2000). The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics. Biochemistry 39(38):11777-87. crossref |
||||
|
Turos E, Reddy GS, Greenhalgh K, Ramaraju P, Abeylath SC, Jang S, Dickey S, Lim DV (2007). Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA. Bioorg. Med. Chem. Lett. 17(12): 3468-72. crossref |
||||
|
Ubukata K, Nonoguchi R, Matsuhashi M, Konno M (1989). Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J. Bacteriol. 171(5): 2882-5. Pubmed |
||||
|
Yokoyama T, Honda J, Kawayama T, Kajimura K, Oizumi K (1996). Increased incidence of beta-lactamase-plasmid negative, high level methicillin-resistant Staphylococcus aureus (MRSA). Kurume Med. J.　43(3):199-206. crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
